Simultaneous determination of Sulphadoxine and Pyrimethamine by taking Tolterodine as an internal standard in Pharmaceutical dosage form by RP-HPLC

 

Dr. Sushil D. Patil2*, Pravin B. Shelke1*, Priti Aher1, Maswood Ahmed Hafizur Rahman1

1MET’s Institute of Pharmacy, MET League of Colleges, Bhujbal Knowledge City, Adgaon, Nashik, Maharashtra State 422003, India.

2Department of Pharmaceutical Chemistry, MET's Institute of Pharmacy, Bhujbal Knowledge City, Adgaon Nashik, Maharashtra, India.

*Corresponding Author E-mail: sushilpharmamet@gmail.com

 

ABSTRACT:

A simple, rapid, economic, sensitive and precise HPLC method has been developed for the simultaneous determination of Sulphadoxine and Pyrimethamine in pharmaceutical dosage form by taking Tolterodine as an internal standard. The method was carried out using Phenomenex C18 (4.6ID × 250mm; 5µm) column and mobile phase comprised of methanol and Phosphate Buffer in proportion of ratio 60:40 v/v. The flow rate was 1.0mL/min and detection was carried out at 276nm. The retention time of Sulphadoxine, Pyrimethamine and Tolterodine were found to be 2.967, 4.058 and 6.908 respectively. Linearity of Sulphadoxine and Pyrimethamine in the range of 2 to 12μg/mL and 4 to 24μg/mL respectively. The % recoveries of Sulphadoxine and Pyrimethamine were found to be in between 99.93% to 99. 96 % respectively. The proposed method is suitable for the routine quality control analysis for simultaneous determination of Sulphadoxine and Pyrimethamine was in bulk and pharmaceutical dosage form.

 

KEYWORDS: Sulphadoxine, Pyrimethamine, Tolterodine RP-HPLC, Simultaneous estimation, Stress testing, Validation.

 

 


1. INTRODUCTION:

Method development and optimization in liquid chromatography is still an attractive field of research for the researchers and attracts also a lot of interest from practical analysts. Complex mixtures or samples required systematic method development involving accurate modeling of the retention behavior of the analyte.

 

Among all, the liquid chromatographic methods, the reversed phase systems based on modified silica offers the highest probability of successful results. However, a large number of (system) variables (parameters) affect the selectivity and the resolution.

 

Many methods reported for determination of Sulphadoxine and Pyrimethamine in pharmaceutical dosage form as well as stability indicating methods.6-9

 

Proposed method was innovative simple robust and cost effective by taking Tolterodine as an internal standard.

 

1. Sulfadoxine:

 

Fig. No 1: Chemical structure of Sulfadoxine

 

2. Pyrimethamine:

 

Fig No. 2: Chemical structure of Atenolol

 

3. Tolterodine:

 

Fig No 3: Chemical structure of Tolterodine

 

2. MATERIALS AND METHODS:

2.1. Apparatus and Equipments:

HPLC instrumentation consisting of pump PU-2080 plus (JASCO, Tokyo, Japan), with Rheodyne manual loop injector 7725i (injection loop capacity 20𝜇L) was used. Detection was carried out using UV-2075 detector (JASCO, Tokyo, Japan). Data acquisition was done by Borwin chromatography software version 1.5 (JASCO, Tokyo, Japan). All calculations were performed using Microsoft Excel 2010 (Microsoft Corporation).

 

2.2.  Reagents and Chemicals:

Pharmaceutical grade Sulfadoxine, Pyrimethamine was supplied as a gift sample from Ipca laboratories pvt ltd Andheri, Mumbai. Methanols used in analysis were of HPLC grade and all other chemicals and reagents were of analytical grade and were purchased from SD Fine Chemicals, Mumbai, India. Double distilled water used was freshly prepared by Double Distillation Assembly (Borosil, Mumbai, India) and further used in analysis after filtering through 0.45μ membrane filter papers purchased from Millipore (India) Pvt. Ltd., Bengaluru, India. Sulfadoxine and Pyrimethamine purches from local medical store (label claim 500mg and 25mg/tablet).

 

2.3. Chromatographic Conditions.

All chromatographic separations were carried out on Phenomenex Hyper Clone C 18 column (250 × 4.6mm, 5𝜇), using mobile phase comprising methanol: Phosphate buffer 60:40% v/v. The flow rate was kept constant throughout analysis at 1.0mL/min and eluent was detected at 276nm by UV- detector.

 

2.4. Standard Preparation:

Standard solution were prepared by dissolving 10mg of Sulfadoxine, 10mg of Pyrimethamine and 10mg of Tolterodine into a 100mL clean dry volumetric flask, add about 75mL of methanol and sonicate to dissolve it completely and make volume up to the mark with the diluent. Pipette 1mL of the above stock solution for Pyrimethamine and Sulfadoxine and 5ml for Tolterodine into a 10mL volumetric flask and dilute up to the mark with diluents to prepare 10ppm of Pyrimethamine and Sulfadoxine and 50ppm of Tolterodine.

 

Method Validation:

System suitability:

A Standard solution of of Sulphadoxine, Pyrimethamine and Tolterodine working standard was prepared as per procedure and was injected six times into the HPLC system. The system suitability parameters were evaluated from standard chromatograms obtained by calculating the %RSD of retention time, tailing factor, theoretical plates and peak areas from six replicate injections are within range and results were shown in Table No.1 -3.

 

Linearity:

Linearity is the ability of the method to elicit test results that are proportional to concentration of the analyte in the sample.

 

It was found to be in the range of 2 to 12μg/ml for Sulfadoxine and 4 to 24μg/ml for Pyrimethamine in which 50μg/ml of Tolterodine can be added each time. The calibration graph was plotted, and the drug was found to be linear with a correlation coefficient (r2) of 0.995 were shown in Fig. 5 and 6

 

Accuracy and Precision:

It is the closeness of test results obtained by the method to the true value. It was determined by percent recovery of the standard API to the blank and It is the degree of agreement among individual test results when the procedure is applied repeatedly to multiple samplings. It was determined by studying repeatability, intra-day and inter-day precision of method.1-5 The average recovery of the analyte of 80%, 100% and 120% solution. The amount found (mg) and %RSD was calculated and were shown in Table No.7-9

 

Specificity:

Specificity is the ability to measure unequivocally the desired analyte in the presence of components such as excipients and impurities. Here, dextrose was used as excipient. Three solution of 10μg/mL was injected and one excipient solution as a blank injected and compare the chromatogram with the standard solution of Sulfadoxine and Pyrimethamine were shown in Fig. No.7

 

Robustness:

It is the capacity of the method to remain unaffected by small but deliberate variations in method parameters.3,4,8 The analysis was performed by slightly changing the wavelength (220nm and 228nm), mobile phase composition (65:35 and 55:45%v/v) and flow rate (0.8 and 1.2mL/min). The variables are shown in Table No.10

 

Limit of Detection (LOD):

LOD is the lowest level of concentration of analyte in the sample that can be detected, though not necessarily quantitated. It is calculated to be 0.913μg/mL for Sulfadoxine and 1.29μg/mL for Pyrimethamine by using the formula,

 

LOD= 3.3σ/S

Where,

σ = Standard deviation of the response,

S = Slope of calibration curve.

 

Limit of Quantitation (LOQ):

LOQ is the lowest concentration of analyte in a sample that may be determined with acceptable accuracy and precision when the required procedure is applied.1-5 It was calculated to be 2.769μg/mLfor Sulfadoxine and 3.93μg/mL for Pyrimethamine by using the formula,

 

LOQ=10σ/S

 

Where,

σ = Standard deviation of the response,

S = Slope of calibration curve.

 

3.    RESULTS AND DISCUSSION:

Table No 1: Result for system suitability test of Sulfadoxine

Sample Name

Retention Time (min)

Area

Plate Count

Asymmetry

Standard 1

2.925

1140860

10470

1.18

Standard 2

2.925

1143927

10476

1.18

Standard 3

2.983

1208848

10576

1.22

Standard 4

2.983

1151378

10646

1.14

Standard 5

2.925

1233716

10567

1.2

Mean

 

5878729

 

S.D

42660.12

% RSD

0.725669

 

Table No 2: Result for system suitability test of Pyrimethamine

Sample Name

Retention Time (min)

Area

Plate Count

Asymmetry

Standard 1

4.075

577584

6237

1.3

Standard 2

4.075

642174

6346

1.29

Standard 3

4.008

592684

5805

1.32

Standard 4

4.075

546048

5720

1.29

Standard 5

4.008

579625

5712

1.39

Mean

 

2938115

 

 S.D

34980.91

 

Table No. 3: Result for system suitability test of Tolterodine

Sample Name

Retention Time (min)

Area

Plate Count

Asymmetry

Standard 1

6.908

302090

6550

1.39

Standard 2

6.742

315354

6848

1.48

Standard 3

6.908

315578

6776

1.43

Standard 4

6.742

312266

6637

1.5

Standard 5

6.742

321672

6335

1.44

Mean

 

 

1566960

 

 

 S.D

7179.65

 % RSD

0.45819

 


 

Fig No. 4: Chromatogram of System Suitability Test for Sulfadoxine, Pyrimethamine and Tolterodine


 


Table No 4: Result of System Suitability Test for Sulfadoxine, Pyrimethamine and Tolterodine

Sr. No.

Peak Name

Retention Time

Area

Resolution

Plate Count

Asymmetry

1

Sulfadoxine

2.983

1140860

0.00

10470

1.18

2

Pyrimethamine

4.075

577584

6.075

6237

1.3

 

Tolterodine

6.908

302090

10.131

6550

1.39

 


Table No. 5: Result and Statistical data of Linearity (Sulfadoxine)

Sr. No.

Concentration (µg ml-1)

Area ratio of Drug and IS

1

2

0.731719

2

4

1.68912

3

6

2.402375

4

8

3.009254

5

10

3.73827

6

12

4.41881

 

Correlation Coefficient

0.995

Slope (m)

0.359

Intercept (y)

0.145

 

Table No 6: Result and Statistical data of Linearity (Pyrimethamine)

Sr. No.

Concentration (µg ml-1)

Area ratio of Drug and IS

1

4

0.7268

2

8

1.5237

3

12

2.2128

4

16

2.7804

5

20

3.6722

6

24

4.5369

 

Correlation Coefficient

0.995

Slope (m)

0.186

Intercept (y)

0.030

 

Fig No. 5: Linearity plot of Sulfadoxine

 

Fig No. 6: Linearity plot of Pyrimethamine



Table No. 7: Result and Statistical data of Accuracy (Sulfadoxine)

Sr. No.

Conc. Level %

Conc. (µg/mL)

Area/Ratio of sulfadoxine+IS

Conc. Found (µg/mL)

% Recovery

% mean Recovery

% RSD

Sample taken

Pure API spiked

1.

80

5

3

3.05243733

8.09871

101.2339

 

99.93

 

 

1.149

 

2.

80

5

3

3.01287727

7.98851

99.85645

3.

80

5

3

2.98685567

7.91603

98.95041

4.

100

5

5

3.70483655

9.91597

99.15979

 

99.944

 

0.680

 

5.

100

5

5

3.74604186

10.0307

100.3076

6.

100

5

5

3.74811236

10.0365

100.3653

7.

120

5

7

4.45612234

12.0086

100.0725

 

99.93407

 

0.732

 

8.

120

5

7

4.41605907

11.8971

99.1425

9.

120

5

7

4.47829791

12.0704

100.5872

 

Average

99.933

0.853

 

Table No 8: Result and Statistical data of Accuracy (Pyrimethamine)

Sr. No.

Conc. Level %

Conc. (µg/mL)

Area/Ratio of sulfadoxine+IS

Conc. Found (µg/mL)

% Recovery

% mean Recovery

% RSD

Sample taken

Pure API spiked

1.

80

5

3

1.542608

8.1323

101.2339

 

100.0136

 

1.092

2.

80

5

3

1.516442

7.99162

99.85645

3.

80

5

3

1.512626

7.97110

98.95041

4.

100

5

5

1.858846

9.83250

99.15979

 

99.9442

 

1.056

5.

100

5

5

1.839284

9.72733

100.3076

6.

100

5

5

1.87793

9.93510

100.3653

7.

120

5

7

2.224601

11.7989

100.0725

 

99.93407

 

1.245

8.

120

5

7

2.204149

11.6889

99.1425

9.

120

5

7

2.258393

11.9806

100.5872

 

Average

99.96395

1.131

 

Table No. 9: Results and Statistical data of Method Precision

Injection No.

Sulfadoxine (10ppm)

Pyrimethamine (10ppm)

Retention Time(min)

Area

Retention Time(min)

Area

1

 2.958

3.734912

4.075

1.895277

2

2.958

3.734025

4.117

1.881342

3

2.958

3.70559

4.108

1.885424

4

3.067

3.713505

4.183

1.886704

5

3.067

3.716563

4.300

1.895648

6

3.150

3.71597

4.183

1.884638

Mean

 

3.720094

 

1.882685

S.D.

0.032886

0.026177

%RSD

0.884006

1.39041

 

Fig No.7: Representative Chromatogram of Specificity

 


Table No. 10: Robustness studies by 23 Factorial Design

Parameter

Variables

+

-

Flow rate (1mL/min)

0.2mL

0.2mL

Mobile phase (70:30%v/v)

10%

10%

Wavelength (224nm)

4nm

4nm

From the above variables, only retention time was change with respect to change in flow rate of mobile phase and mobile phase ratio. Hence, all variable of the method was robust.

 

4. CONCLUSION:

In conclusion, a simple, selective, sensitive and accurate stability indicating RP-HPLC method was developed and validated for the analysis of Sulfadoxine and Pyrimethamine with tolterodine as an internal standard. The retention time of Sulphadoxine, Pyrimethamine and Tolterodine were found to be 2.967, 4.058 and 6.908 respectively Linearity of Sulphadoxine and Pyrimethamine in the range of 2 to 12μg/mL and 4 to 24μg/mL respectively. The % recoveries of Sulphadoxine and Pyrimethamine were found to be in between 99.93% to 99. 96% respectively.

 

Further the method was found to be linear, precise, accurate and robust. The degradation studies will not carried out due to stickiness of drug to the column. Hence the proposed method can be used for the estimation of Sulfadoxine and pyrimethamine in routine analysis.

 

5. ACKNOWLEDGMENT:

The authors are thankful to the management and trustees of Mumbai Educational Trust’s Bhujbal Knowledge City, Nashik, for providing necessary chemicals and analytical facilities and to Ipca Laboratories Andheri, Mumbai, for providing pharmaceutical grade Sulfadoxine and Pyrimethamine as gift sample.

 

6. REFERENCE:

1.      Christen GD. Analytical Chemistry. 5th ed. John Wiley and Sons; 2003; 35-42, 131-132.

2.      Sharma BK. Instrumental Methods of Chemical Analysis. 25th ed. Meerut: Goel Publication Co; 1983; 3: 6.

3.      Skoog DA, Holler FJ, Crouch SR. Principle of Instrumental Analysis. 6th ed. India: Thomson Publications; 2007; 1-3: 145-147, 180.

4.      ICH, Q2 (R1); Validation of analytical procedures: text and methodology. International Conference on Harmonization, Geneva; 2005; 1- 13.

5.      Nash R.; Pharmaceutical Process Validation; 3rd edition; Marcel Dekker Publication; New York; 107; 2002: 340-370.

6.      K S Nataraj, K Chaitanya, K Alekhya, B. Surendra Babu, K Gnananath. Simultaneous estimation of Sulfadoxine and Pyrimethamine in Bulk and tablet dosage form. International Journal of Environmental Chemistry and Chromatography 2015(1): 8-14

7.      B. Hari babu, Kasthuri Jyoti K, Satyanarayana P.V.V, Kumari Kusuma M.A validated liquid chromatographic method for the Determination of Sulfadoxine and Pyrimethamine in pharmaceutical formulation. World Journal of Pharmacy and Pharmaceutical Sciences 2014; 3(10): 1032-1042.

8.      Vemula Venkata Raveendra Babu, Sharma Pankaj Kumar V, Singhvi Indrajit. HPLC method development and validation of simultaneous estimation of sulfadoxine and pyrimethamine in Tablet dosage form. International Journal of Pharma Sciences 2013; 3(4): 295-298.

9.      Ambalkar S. U, Bakal R. L, Dewani A. P, Chandewar A. V. HPLC-DAD determination of Sulfadoxine, Pyrimethamine and Artisunate in a kit of Tablets, validation and application in vitro dissolution study. International Journal of Drug Formulation and Research 2013; 4(5).

 

 

 

Received on 30.12.2020        Revised on 27.01.2021                                                                                                           

Accepted on 17.02.2021     ©Asian Pharma Press All Right Reserved

Asian Journal of Pharmaceutical Analysis. 2021; 11(2):145-150.

DOI: 10.52711/2231-5675.2021.00025